The only device you need is the phone already in your pocket. AI turns it into a whole-person health monitor.
Most remote patient monitoring dies at the loading dock. The cuffs and pulse-oximeters are expensive, they get lost, and a large share of patients never take them out of the box. Percipio Health, based in Plano, Texas, was built around a plainer idea: the richest health sensor most people own is the smartphone they never think of as medical.
Founded by digital-health veterans Eric Rock and David Lucas, Percipio uses artificial intelligence to read health signals directly from a phone - no dedicated medical devices attached. Point the camera and vision-based AI biomarkers estimate vitals and check medication adherence. Speak a few sentences and vocal AI biomarkers screen for changes in brain health. The platform folds in social determinants of health to build a whole-person picture that updates continuously rather than once a year.
The company emerged from stealth in January 2025 with a $20 million Series A led by UPMC Enterprises, alongside Labcorp, WAVE Ventures and First Trust Capital Partners. Behind it is a founding team on its third company in the category: they built MEDHOST, an emergency-department records system acquired in 2010, then Vivify Health, a remote monitoring platform acquired by UnitedHealth Group's Optum in 2019. Percipio is the version they could only build once AI made the phone itself the instrument.
"After two years of intensive R&D, we are thrilled to unveil Percipio Health, breaking through the high-cost barriers that have prevented remote patient monitoring from reaching broader populations."
Four moves take Percipio from a patient's phone to a clinician's next action.
A single mobile app collects daily whole-person signals - vision, voice and self-report - with no add-on hardware.
Vision AI estimates vitals and medication adherence; vocal AI screens brain health; models weigh social determinants.
Signals feed real-time and predictive risk assessment, flagging current and emerging risk across a population.
The clinical portal generates automated care plans and "next best action" prompts so small teams can respond at scale.
Smartphone-based, device-free remote monitoring that collects whole-person signals for real-time and predictive risk across large populations.
Vision biomarkers read vitals and medication adherence via the camera; vocal biomarkers screen brain health; models capture social determinants.
AI assesses risk and generates automated care plans with "next best action" prompts, letting a small team manage a big population.
A provider- and payer-facing portal delivering predictive, proactive and personalized insight for value-based care.
Traditional remote patient monitoring only pencils out for the sickest, highest-cost patients - the ones whose care justifies buying and shipping a device. That leaves out the rising-risk population, the people who are not acute today but churn toward crisis if no one is watching. "Risk isn't static, it churns," the company argues, and a once-a-year snapshot misses the movement.
By removing the device cost, Percipio inverts the math. When the hardware is effectively nothing, the addressable group stops being "sick enough to justify the box" and becomes "anyone with a phone" - including rural and underserved communities. That is the gap between Percipio and connected-device incumbents such as Current Health, BioIntelliSense, HealthSnap and Cadence, and even the founders' own former platform, Vivify Health.
The pitch to payers is equally blunt: intervene earlier, spend less, improve medical loss ratio. Or, as the company frames the staffing math, "turn 5 care coordinators into a population health engine for 10,000 patients." Automation absorbs the busywork so clinicians spend their hours on the patients who actually need a human.
The wager rests on adoption. In digital health, a perfect reading nobody takes is worth nothing, and a device patients ignore is a cost with no return. Percipio's answer is to meet patients on the one screen they already check dozens of times a day.
"This ability to make the patient's phone a pivotal part of healthcare may provide powerful health insights, second only to genetics."
- Dr. Andrew R. Watson, UPMC
"With Percipio, this need can be accomplished at scale, at lower cost, with higher fidelity, transparency, and visibility of the data."
- Dr. Cameron Powell, WAVE Ventures
"Payers and providers can now reach and understand a much broader population, of both rising and high risk, to ensure they receive the proactive attention they need."
- David Lucas, Co-Founder & CSO
Percipio's January 2025 Series A brought in a syndicate that reads like a strategy statement: a health system, a diagnostics giant and a health-focused venture firm.
The company sells B2B to health plans, health systems and rural health organizations operating under value-based contracts - where keeping people out of the hospital, rather than billing for visits, is how everyone gets paid. UPMC's Dr. Andrew Watson has joined as a senior medical advisor, and UPMC Enterprises describes the tie-up as a push to advance AI-driven asynchronous population health monitoring.
Rock and Lucas's emergency-department records and workflow company is acquired by HealthTech Holdings.
Their remote patient monitoring platform is acquired by UnitedHealth Group's Optum division.
The team begins roughly two years of R&D on smartphone-based, device-free AI health monitoring.
Percipio emerges from stealth in North Texas, closing a round led by UPMC Enterprises with Labcorp and WAVE Ventures.
Video interviews & product demos: Percipio Health does not maintain a public YouTube channel at time of writing. For on-camera commentary, see Eric Rock's discussion with Chief Healthcare Executive, and watch the company's LinkedIn page for demo clips as they are posted.